Clinical efficacy of the aromatase inhibitor anastrozole in relation to prolactin secretion in heavily pretreated metastatic breast cancer

Tumori

Volumn 84, Issue 1, 1998, Pages 45-47

  Barni, Sandro ^a   Lissoni, Paolo ^a   Meregalli, Sofia ^a   Ardizzoia, Antonio ^a   Mengo, Susan ^a   Musco, Flavia ^a   Merlini, Desirée ^a   Tancini, Gabriele ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Anastrozole; Aromatase inhibitors; Breast cancer; Prolactin

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; PROLACTIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESTROGEN METABOLISM; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PROLACTIN RELEASE;

EID: 0031945698     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169808400109     Document Type: Article

References (7)

1. Bajetta E., Cello L., Buzzoni R., Bichisao E.: Novel non-steroidal aromatase inhibitors: are there new perspectives in the treatment of breast cancer? Tumori, 82: 417-422, 1996.
2. Holtkamp W., Nagel C.A., Wander H.E., Rauschecker H.F., Heyden D.: Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int. J. Cancer, 34: 323-328, 1984.
3. Plourde P.V., Dyroff M., Dowsett M., Demers L., Yates R., Vebster A.: Arimidex: a new oral, once-a-day aromatase inhibitor. J. Steroid Biochem. Molec. Biol., 53: 175-179, 1995.
4. Reed M.J.: The role of aromatase in breast tumors. Breast Cancer Res. Treat., 30: 7-17, 1994.
5. Wang D.Y., Hampsot S., Kwa H.G.: Serum prolactin levels in women with breast cancer and their relationship to survival. Eur. J. Cancer Clin. Oncol., 22: 487-492, 1986.
6. Welsch C.W., Nagasawa H.: Prolactin and murine mammary tumorigenesis: a review. Cancer Res., 37: 951-963, 1977.
7. Willis K.J., London D.R., Ward H.W.C., Butt W.R., Lynch S.S., Rudd B.T.: Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course. Br. Med. J., 1: 425-428, 1977.